COVID-19 Impact on Global Gene Therapies for Cancer Treatment Market Size, Status and Forecast 2020-2026
In the medicine field, gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Gene Therapies for Cancer Treatment market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Gene Therapies for Cancer Treatment industry.
Based on our recent survey, we have several different scenarios about the Gene Therapies for Cancer Treatment YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Gene Therapies for Cancer Treatment will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapies for Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapies for Cancer Treatment market in terms of revenue.
Players, stakeholders, and other participants in the global Gene Therapies for Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Gene Therapies for Cancer Treatment market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Gene Therapies for Cancer Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapies for Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapies for Cancer Treatment market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Gene Therapies for Cancer Treatment market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Gene Therapies for Cancer Treatment industry.
Based on our recent survey, we have several different scenarios about the Gene Therapies for Cancer Treatment YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Gene Therapies for Cancer Treatment will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapies for Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapies for Cancer Treatment market in terms of revenue.
Players, stakeholders, and other participants in the global Gene Therapies for Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Gene Therapies for Cancer Treatment market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Gene Therapies for Cancer Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapies for Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapies for Cancer Treatment market.
The following players are covered in this report:
- Takara Bio
- Tocagen
- VBL Therapeutics
- Cold Genesys
- Genprex
- Momotaro-Gene
- MultiVir
- SynerGene Therapeutics
- Ziopharm Oncology
- Anchiano Therapeutics
- Celgene
- Celsion
- Bluebird Bio
- Somatic Cell Gene Therapy (SCGT)
- Germline Gene Therapy (GGT)
- Cancer Research Centers
- Diagnostic Laboratories
- Cancer Hospitals
- Others
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gene Therapies for Cancer Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Somatic Cell Gene Therapy (SCGT)
1.4.3 Germline Gene Therapy (GGT)
1.5 Market by Application
1.5.1 Global Gene Therapies for Cancer Treatment Market Share by Application: 2020 VS 2026
1.5.2 Cancer Research Centers
1.5.3 Diagnostic Laboratories
1.5.4 Cancer Hospitals
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Gene Therapies for Cancer Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Gene Therapies for Cancer Treatment Industry
1.6.1.1 Gene Therapies for Cancer Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Gene Therapies for Cancer Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Gene Therapies for Cancer Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Gene Therapies for Cancer Treatment Market Perspective (2015-2026)
2.2 Gene Therapies for Cancer Treatment Growth Trends by Regions
2.2.1 Gene Therapies for Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gene Therapies for Cancer Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Gene Therapies for Cancer Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gene Therapies for Cancer Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Gene Therapies for Cancer Treatment Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Gene Therapies for Cancer Treatment Players by Market Size
3.1.1 Global Top Gene Therapies for Cancer Treatment Players by Revenue (2015-2020)
3.1.2 Global Gene Therapies for Cancer Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Gene Therapies for Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gene Therapies for Cancer Treatment Market Concentration Ratio
3.2.1 Global Gene Therapies for Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gene Therapies for Cancer Treatment Revenue in 2019
3.3 Gene Therapies for Cancer Treatment Key Players Head office and Area Served
3.4 Key Players Gene Therapies for Cancer Treatment Product Solution and Service
3.5 Date of Enter into Gene Therapies for Cancer Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Gene Therapies for Cancer Treatment Historic Market Size by Type (2015-2020)
4.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Type (2021-2026)
5 GENE THERAPIES FOR CANCER TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
5.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Gene Therapies for Cancer Treatment Market Size (2015-2020)
6.2 Gene Therapies for Cancer Treatment Key Players in North America (2019-2020)
6.3 North America Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
6.4 North America Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Gene Therapies for Cancer Treatment Market Size (2015-2020)
7.2 Gene Therapies for Cancer Treatment Key Players in Europe (2019-2020)
7.3 Europe Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
7.4 Europe Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
8 CHINA
8.1 China Gene Therapies for Cancer Treatment Market Size (2015-2020)
8.2 Gene Therapies for Cancer Treatment Key Players in China (2019-2020)
8.3 China Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
8.4 China Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Gene Therapies for Cancer Treatment Market Size (2015-2020)
9.2 Gene Therapies for Cancer Treatment Key Players in Japan (2019-2020)
9.3 Japan Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
9.4 Japan Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Gene Therapies for Cancer Treatment Market Size (2015-2020)
10.2 Gene Therapies for Cancer Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
11 INDIA
11.1 India Gene Therapies for Cancer Treatment Market Size (2015-2020)
11.2 Gene Therapies for Cancer Treatment Key Players in India (2019-2020)
11.3 India Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
11.4 India Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Gene Therapies for Cancer Treatment Market Size (2015-2020)
12.2 Gene Therapies for Cancer Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
12.4 Central & South America Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Takara Bio
13.1.1 Takara Bio Company Details
13.1.2 Takara Bio Business Overview and Its Total Revenue
13.1.3 Takara Bio Gene Therapies for Cancer Treatment Introduction
13.1.4 Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2015-2020))
13.1.5 Takara Bio Recent Development
13.2 Tocagen
13.2.1 Tocagen Company Details
13.2.2 Tocagen Business Overview and Its Total Revenue
13.2.3 Tocagen Gene Therapies for Cancer Treatment Introduction
13.2.4 Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
13.2.5 Tocagen Recent Development
13.3 VBL Therapeutics
13.3.1 VBL Therapeutics Company Details
13.3.2 VBL Therapeutics Business Overview and Its Total Revenue
13.3.3 VBL Therapeutics Gene Therapies for Cancer Treatment Introduction
13.3.4 VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
13.3.5 VBL Therapeutics Recent Development
13.4 Cold Genesys
13.4.1 Cold Genesys Company Details
13.4.2 Cold Genesys Business Overview and Its Total Revenue
13.4.3 Cold Genesys Gene Therapies for Cancer Treatment Introduction
13.4.4 Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
13.4.5 Cold Genesys Recent Development
13.5 Genprex
13.5.1 Genprex Company Details
13.5.2 Genprex Business Overview and Its Total Revenue
13.5.3 Genprex Gene Therapies for Cancer Treatment Introduction
13.5.4 Genprex Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
13.5.5 Genprex Recent Development
13.6 Momotaro-Gene
13.6.1 Momotaro-Gene Company Details
13.6.2 Momotaro-Gene Business Overview and Its Total Revenue
13.6.3 Momotaro-Gene Gene Therapies for Cancer Treatment Introduction
13.6.4 Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
13.6.5 Momotaro-Gene Recent Development
13.7 MultiVir
13.7.1 MultiVir Company Details
13.7.2 MultiVir Business Overview and Its Total Revenue
13.7.3 MultiVir Gene Therapies for Cancer Treatment Introduction
13.7.4 MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
13.7.5 MultiVir Recent Development
13.8 SynerGene Therapeutics
13.8.1 SynerGene Therapeutics Company Details
13.8.2 SynerGene Therapeutics Business Overview and Its Total Revenue
13.8.3 SynerGene Therapeutics Gene Therapies for Cancer Treatment Introduction
13.8.4 SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
13.8.5 SynerGene Therapeutics Recent Development
13.9 Ziopharm Oncology
13.9.1 Ziopharm Oncology Company Details
13.9.2 Ziopharm Oncology Business Overview and Its Total Revenue
13.9.3 Ziopharm Oncology Gene Therapies for Cancer Treatment Introduction
13.9.4 Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
13.9.5 Ziopharm Oncology Recent Development
13.10 Anchiano Therapeutics
13.10.1 Anchiano Therapeutics Company Details
13.10.2 Anchiano Therapeutics Business Overview and Its Total Revenue
13.10.3 Anchiano Therapeutics Gene Therapies for Cancer Treatment Introduction
13.10.4 Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
13.10.5 Anchiano Therapeutics Recent Development
13.11 Celgene
10.11.1 Celgene Company Details
10.11.2 Celgene Business Overview and Its Total Revenue
10.11.3 Celgene Gene Therapies for Cancer Treatment Introduction
10.11.4 Celgene Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
10.11.5 Celgene Recent Development
13.12 Celsion
10.12.1 Celsion Company Details
10.12.2 Celsion Business Overview and Its Total Revenue
10.12.3 Celsion Gene Therapies for Cancer Treatment Introduction
10.12.4 Celsion Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
10.12.5 Celsion Recent Development
13.13 Bluebird Bio
10.13.1 Bluebird Bio Company Details
10.13.2 Bluebird Bio Business Overview and Its Total Revenue
10.13.3 Bluebird Bio Gene Therapies for Cancer Treatment Introduction
10.13.4 Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
10.13.5 Bluebird Bio Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gene Therapies for Cancer Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Somatic Cell Gene Therapy (SCGT)
1.4.3 Germline Gene Therapy (GGT)
1.5 Market by Application
1.5.1 Global Gene Therapies for Cancer Treatment Market Share by Application: 2020 VS 2026
1.5.2 Cancer Research Centers
1.5.3 Diagnostic Laboratories
1.5.4 Cancer Hospitals
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Gene Therapies for Cancer Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Gene Therapies for Cancer Treatment Industry
1.6.1.1 Gene Therapies for Cancer Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Gene Therapies for Cancer Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Gene Therapies for Cancer Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Gene Therapies for Cancer Treatment Market Perspective (2015-2026)
2.2 Gene Therapies for Cancer Treatment Growth Trends by Regions
2.2.1 Gene Therapies for Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gene Therapies for Cancer Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Gene Therapies for Cancer Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gene Therapies for Cancer Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Gene Therapies for Cancer Treatment Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Gene Therapies for Cancer Treatment Players by Market Size
3.1.1 Global Top Gene Therapies for Cancer Treatment Players by Revenue (2015-2020)
3.1.2 Global Gene Therapies for Cancer Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Gene Therapies for Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gene Therapies for Cancer Treatment Market Concentration Ratio
3.2.1 Global Gene Therapies for Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gene Therapies for Cancer Treatment Revenue in 2019
3.3 Gene Therapies for Cancer Treatment Key Players Head office and Area Served
3.4 Key Players Gene Therapies for Cancer Treatment Product Solution and Service
3.5 Date of Enter into Gene Therapies for Cancer Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Gene Therapies for Cancer Treatment Historic Market Size by Type (2015-2020)
4.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Type (2021-2026)
5 GENE THERAPIES FOR CANCER TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
5.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Gene Therapies for Cancer Treatment Market Size (2015-2020)
6.2 Gene Therapies for Cancer Treatment Key Players in North America (2019-2020)
6.3 North America Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
6.4 North America Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Gene Therapies for Cancer Treatment Market Size (2015-2020)
7.2 Gene Therapies for Cancer Treatment Key Players in Europe (2019-2020)
7.3 Europe Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
7.4 Europe Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
8 CHINA
8.1 China Gene Therapies for Cancer Treatment Market Size (2015-2020)
8.2 Gene Therapies for Cancer Treatment Key Players in China (2019-2020)
8.3 China Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
8.4 China Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Gene Therapies for Cancer Treatment Market Size (2015-2020)
9.2 Gene Therapies for Cancer Treatment Key Players in Japan (2019-2020)
9.3 Japan Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
9.4 Japan Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Gene Therapies for Cancer Treatment Market Size (2015-2020)
10.2 Gene Therapies for Cancer Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
11 INDIA
11.1 India Gene Therapies for Cancer Treatment Market Size (2015-2020)
11.2 Gene Therapies for Cancer Treatment Key Players in India (2019-2020)
11.3 India Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
11.4 India Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Gene Therapies for Cancer Treatment Market Size (2015-2020)
12.2 Gene Therapies for Cancer Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
12.4 Central & South America Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Takara Bio
13.1.1 Takara Bio Company Details
13.1.2 Takara Bio Business Overview and Its Total Revenue
13.1.3 Takara Bio Gene Therapies for Cancer Treatment Introduction
13.1.4 Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2015-2020))
13.1.5 Takara Bio Recent Development
13.2 Tocagen
13.2.1 Tocagen Company Details
13.2.2 Tocagen Business Overview and Its Total Revenue
13.2.3 Tocagen Gene Therapies for Cancer Treatment Introduction
13.2.4 Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
13.2.5 Tocagen Recent Development
13.3 VBL Therapeutics
13.3.1 VBL Therapeutics Company Details
13.3.2 VBL Therapeutics Business Overview and Its Total Revenue
13.3.3 VBL Therapeutics Gene Therapies for Cancer Treatment Introduction
13.3.4 VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
13.3.5 VBL Therapeutics Recent Development
13.4 Cold Genesys
13.4.1 Cold Genesys Company Details
13.4.2 Cold Genesys Business Overview and Its Total Revenue
13.4.3 Cold Genesys Gene Therapies for Cancer Treatment Introduction
13.4.4 Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
13.4.5 Cold Genesys Recent Development
13.5 Genprex
13.5.1 Genprex Company Details
13.5.2 Genprex Business Overview and Its Total Revenue
13.5.3 Genprex Gene Therapies for Cancer Treatment Introduction
13.5.4 Genprex Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
13.5.5 Genprex Recent Development
13.6 Momotaro-Gene
13.6.1 Momotaro-Gene Company Details
13.6.2 Momotaro-Gene Business Overview and Its Total Revenue
13.6.3 Momotaro-Gene Gene Therapies for Cancer Treatment Introduction
13.6.4 Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
13.6.5 Momotaro-Gene Recent Development
13.7 MultiVir
13.7.1 MultiVir Company Details
13.7.2 MultiVir Business Overview and Its Total Revenue
13.7.3 MultiVir Gene Therapies for Cancer Treatment Introduction
13.7.4 MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
13.7.5 MultiVir Recent Development
13.8 SynerGene Therapeutics
13.8.1 SynerGene Therapeutics Company Details
13.8.2 SynerGene Therapeutics Business Overview and Its Total Revenue
13.8.3 SynerGene Therapeutics Gene Therapies for Cancer Treatment Introduction
13.8.4 SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
13.8.5 SynerGene Therapeutics Recent Development
13.9 Ziopharm Oncology
13.9.1 Ziopharm Oncology Company Details
13.9.2 Ziopharm Oncology Business Overview and Its Total Revenue
13.9.3 Ziopharm Oncology Gene Therapies for Cancer Treatment Introduction
13.9.4 Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
13.9.5 Ziopharm Oncology Recent Development
13.10 Anchiano Therapeutics
13.10.1 Anchiano Therapeutics Company Details
13.10.2 Anchiano Therapeutics Business Overview and Its Total Revenue
13.10.3 Anchiano Therapeutics Gene Therapies for Cancer Treatment Introduction
13.10.4 Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
13.10.5 Anchiano Therapeutics Recent Development
13.11 Celgene
10.11.1 Celgene Company Details
10.11.2 Celgene Business Overview and Its Total Revenue
10.11.3 Celgene Gene Therapies for Cancer Treatment Introduction
10.11.4 Celgene Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
10.11.5 Celgene Recent Development
13.12 Celsion
10.12.1 Celsion Company Details
10.12.2 Celsion Business Overview and Its Total Revenue
10.12.3 Celsion Gene Therapies for Cancer Treatment Introduction
10.12.4 Celsion Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
10.12.5 Celsion Recent Development
13.13 Bluebird Bio
10.13.1 Bluebird Bio Company Details
10.13.2 Bluebird Bio Business Overview and Its Total Revenue
10.13.3 Bluebird Bio Gene Therapies for Cancer Treatment Introduction
10.13.4 Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
10.13.5 Bluebird Bio Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Gene Therapies for Cancer Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Gene Therapies for Cancer Treatment Revenue
Table 3. Ranking of Global Top Gene Therapies for Cancer Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Somatic Cell Gene Therapy (SCGT)
Table 6. Key Players of Germline Gene Therapy (GGT)
Table 7. COVID-19 Impact Global Market: (Four Gene Therapies for Cancer Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Gene Therapies for Cancer Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Gene Therapies for Cancer Treatment Players to Combat Covid-19 Impact
Table 12. Global Gene Therapies for Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Gene Therapies for Cancer Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Gene Therapies for Cancer Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Gene Therapies for Cancer Treatment Market Share by Regions (2015-2020)
Table 16. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Gene Therapies for Cancer Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Gene Therapies for Cancer Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Gene Therapies for Cancer Treatment Players
Table 23. Global Gene Therapies for Cancer Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Gene Therapies for Cancer Treatment Market Share by Players (2015-2020)
Table 25. Global Top Gene Therapies for Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapies for Cancer Treatment as of 2019)
Table 26. Global Gene Therapies for Cancer Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Gene Therapies for Cancer Treatment Product Solution and Service
Table 29. Date of Enter into Gene Therapies for Cancer Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Gene Therapies for Cancer Treatment Market Size Share by Type (2015-2020)
Table 33. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Gene Therapies for Cancer Treatment Market Size Share by Application (2015-2020)
Table 35. Global Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Gene Therapies for Cancer Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020)
Table 39. North America Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Gene Therapies for Cancer Treatment Market Share by Type (2015-2020)
Table 41. North America Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Gene Therapies for Cancer Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020)
Table 45. Europe Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Gene Therapies for Cancer Treatment Market Share by Type (2015-2020)
Table 47. Europe Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Gene Therapies for Cancer Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020)
Table 51. China Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Gene Therapies for Cancer Treatment Market Share by Type (2015-2020)
Table 53. China Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Gene Therapies for Cancer Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020)
Table 57. Japan Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Gene Therapies for Cancer Treatment Market Share by Type (2015-2020)
Table 59. Japan Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Gene Therapies for Cancer Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020)
Table 63. Southeast Asia Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Gene Therapies for Cancer Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Gene Therapies for Cancer Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020)
Table 69. India Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Gene Therapies for Cancer Treatment Market Share by Type (2015-2020)
Table 71. India Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Gene Therapies for Cancer Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020)
Table 75. Central & South America Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Gene Therapies for Cancer Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Gene Therapies for Cancer Treatment Market Share by Application (2015-2020)
Table 79. Takara Bio Company Details
Table 80. Takara Bio Business Overview
Table 81. Takara Bio Product
Table 82. Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 83. Takara Bio Recent Development
Table 84. Tocagen Company Details
Table 85. Tocagen Business Overview
Table 86. Tocagen Product
Table 87. Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 88. Tocagen Recent Development
Table 89. VBL Therapeutics Company Details
Table 90. VBL Therapeutics Business Overview
Table 91. VBL Therapeutics Product
Table 92. VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 93. VBL Therapeutics Recent Development
Table 94. Cold Genesys Company Details
Table 95. Cold Genesys Business Overview
Table 96. Cold Genesys Product
Table 97. Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 98. Cold Genesys Recent Development
Table 99. Genprex Company Details
Table 100. Genprex Business Overview
Table 101. Genprex Product
Table 102. Genprex Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 103. Genprex Recent Development
Table 104. Momotaro-Gene Company Details
Table 105. Momotaro-Gene Business Overview
Table 106. Momotaro-Gene Product
Table 107. Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 108. Momotaro-Gene Recent Development
Table 109. MultiVir Company Details
Table 110. MultiVir Business Overview
Table 111. MultiVir Product
Table 112. MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 113. MultiVir Recent Development
Table 114. SynerGene Therapeutics Business Overview
Table 115. SynerGene Therapeutics Product
Table 116. SynerGene Therapeutics Company Details
Table 117. SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 118. SynerGene Therapeutics Recent Development
Table 119. Ziopharm Oncology Company Details
Table 120. Ziopharm Oncology Business Overview
Table 121. Ziopharm Oncology Product
Table 122. Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 123. Ziopharm Oncology Recent Development
Table 124. Anchiano Therapeutics Company Details
Table 125. Anchiano Therapeutics Business Overview
Table 126. Anchiano Therapeutics Product
Table 127. Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 128. Anchiano Therapeutics Recent Development
Table 129. Celgene Company Details
Table 130. Celgene Business Overview
Table 131. Celgene Product
Table 132. Celgene Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 133. Celgene Recent Development
Table 134. Celsion Company Details
Table 135. Celsion Business Overview
Table 136. Celsion Product
Table 137. Celsion Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 138. Celsion Recent Development
Table 139. Bluebird Bio Company Details
Table 140. Bluebird Bio Business Overview
Table 141. Bluebird Bio Product
Table 142. Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 143. Bluebird Bio Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
Table 1. Gene Therapies for Cancer Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Gene Therapies for Cancer Treatment Revenue
Table 3. Ranking of Global Top Gene Therapies for Cancer Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Somatic Cell Gene Therapy (SCGT)
Table 6. Key Players of Germline Gene Therapy (GGT)
Table 7. COVID-19 Impact Global Market: (Four Gene Therapies for Cancer Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Gene Therapies for Cancer Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Gene Therapies for Cancer Treatment Players to Combat Covid-19 Impact
Table 12. Global Gene Therapies for Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Gene Therapies for Cancer Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Gene Therapies for Cancer Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Gene Therapies for Cancer Treatment Market Share by Regions (2015-2020)
Table 16. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Gene Therapies for Cancer Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Gene Therapies for Cancer Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Gene Therapies for Cancer Treatment Players
Table 23. Global Gene Therapies for Cancer Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Gene Therapies for Cancer Treatment Market Share by Players (2015-2020)
Table 25. Global Top Gene Therapies for Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapies for Cancer Treatment as of 2019)
Table 26. Global Gene Therapies for Cancer Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Gene Therapies for Cancer Treatment Product Solution and Service
Table 29. Date of Enter into Gene Therapies for Cancer Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Gene Therapies for Cancer Treatment Market Size Share by Type (2015-2020)
Table 33. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Gene Therapies for Cancer Treatment Market Size Share by Application (2015-2020)
Table 35. Global Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Gene Therapies for Cancer Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020)
Table 39. North America Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Gene Therapies for Cancer Treatment Market Share by Type (2015-2020)
Table 41. North America Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Gene Therapies for Cancer Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020)
Table 45. Europe Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Gene Therapies for Cancer Treatment Market Share by Type (2015-2020)
Table 47. Europe Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Gene Therapies for Cancer Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020)
Table 51. China Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Gene Therapies for Cancer Treatment Market Share by Type (2015-2020)
Table 53. China Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Gene Therapies for Cancer Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020)
Table 57. Japan Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Gene Therapies for Cancer Treatment Market Share by Type (2015-2020)
Table 59. Japan Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Gene Therapies for Cancer Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020)
Table 63. Southeast Asia Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Gene Therapies for Cancer Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Gene Therapies for Cancer Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020)
Table 69. India Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Gene Therapies for Cancer Treatment Market Share by Type (2015-2020)
Table 71. India Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Gene Therapies for Cancer Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020)
Table 75. Central & South America Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Gene Therapies for Cancer Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Gene Therapies for Cancer Treatment Market Share by Application (2015-2020)
Table 79. Takara Bio Company Details
Table 80. Takara Bio Business Overview
Table 81. Takara Bio Product
Table 82. Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 83. Takara Bio Recent Development
Table 84. Tocagen Company Details
Table 85. Tocagen Business Overview
Table 86. Tocagen Product
Table 87. Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 88. Tocagen Recent Development
Table 89. VBL Therapeutics Company Details
Table 90. VBL Therapeutics Business Overview
Table 91. VBL Therapeutics Product
Table 92. VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 93. VBL Therapeutics Recent Development
Table 94. Cold Genesys Company Details
Table 95. Cold Genesys Business Overview
Table 96. Cold Genesys Product
Table 97. Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 98. Cold Genesys Recent Development
Table 99. Genprex Company Details
Table 100. Genprex Business Overview
Table 101. Genprex Product
Table 102. Genprex Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 103. Genprex Recent Development
Table 104. Momotaro-Gene Company Details
Table 105. Momotaro-Gene Business Overview
Table 106. Momotaro-Gene Product
Table 107. Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 108. Momotaro-Gene Recent Development
Table 109. MultiVir Company Details
Table 110. MultiVir Business Overview
Table 111. MultiVir Product
Table 112. MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 113. MultiVir Recent Development
Table 114. SynerGene Therapeutics Business Overview
Table 115. SynerGene Therapeutics Product
Table 116. SynerGene Therapeutics Company Details
Table 117. SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 118. SynerGene Therapeutics Recent Development
Table 119. Ziopharm Oncology Company Details
Table 120. Ziopharm Oncology Business Overview
Table 121. Ziopharm Oncology Product
Table 122. Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 123. Ziopharm Oncology Recent Development
Table 124. Anchiano Therapeutics Company Details
Table 125. Anchiano Therapeutics Business Overview
Table 126. Anchiano Therapeutics Product
Table 127. Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 128. Anchiano Therapeutics Recent Development
Table 129. Celgene Company Details
Table 130. Celgene Business Overview
Table 131. Celgene Product
Table 132. Celgene Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 133. Celgene Recent Development
Table 134. Celsion Company Details
Table 135. Celsion Business Overview
Table 136. Celsion Product
Table 137. Celsion Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 138. Celsion Recent Development
Table 139. Bluebird Bio Company Details
Table 140. Bluebird Bio Business Overview
Table 141. Bluebird Bio Product
Table 142. Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$)
Table 143. Bluebird Bio Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Gene Therapies for Cancer Treatment Market Share by Type: 2020 VS 2026
Figure 2. Somatic Cell Gene Therapy (SCGT) Features
Figure 3. Germline Gene Therapy (GGT) Features
Figure 4. Global Gene Therapies for Cancer Treatment Market Share by Application: 2020 VS 2026
Figure 5. Cancer Research Centers Case Studies
Figure 6. Diagnostic Laboratories Case Studies
Figure 7. Cancer Hospitals Case Studies
Figure 8. Others Case Studies
Figure 9. Gene Therapies for Cancer Treatment Report Years Considered
Figure 10. Global Gene Therapies for Cancer Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Gene Therapies for Cancer Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Gene Therapies for Cancer Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Gene Therapies for Cancer Treatment Market Share by Players in 2019
Figure 15. Global Top Gene Therapies for Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapies for Cancer Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Gene Therapies for Cancer Treatment Revenue in 2019
Figure 17. North America Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Takara Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Takara Bio Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 26. Tocagen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Tocagen Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 28. VBL Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. VBL Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 30. Cold Genesys Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Cold Genesys Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 32. Genprex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Genprex Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 34. Momotaro-Gene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Momotaro-Gene Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 36. MultiVir Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. MultiVir Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 38. SynerGene Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. SynerGene Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 40. Ziopharm Oncology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Ziopharm Oncology Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 42. Anchiano Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Anchiano Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 44. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Celgene Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 46. Celsion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Celsion Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 48. Bluebird Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Bluebird Bio Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Figure 1. Global Gene Therapies for Cancer Treatment Market Share by Type: 2020 VS 2026
Figure 2. Somatic Cell Gene Therapy (SCGT) Features
Figure 3. Germline Gene Therapy (GGT) Features
Figure 4. Global Gene Therapies for Cancer Treatment Market Share by Application: 2020 VS 2026
Figure 5. Cancer Research Centers Case Studies
Figure 6. Diagnostic Laboratories Case Studies
Figure 7. Cancer Hospitals Case Studies
Figure 8. Others Case Studies
Figure 9. Gene Therapies for Cancer Treatment Report Years Considered
Figure 10. Global Gene Therapies for Cancer Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Gene Therapies for Cancer Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Gene Therapies for Cancer Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Gene Therapies for Cancer Treatment Market Share by Players in 2019
Figure 15. Global Top Gene Therapies for Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapies for Cancer Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Gene Therapies for Cancer Treatment Revenue in 2019
Figure 17. North America Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Takara Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Takara Bio Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 26. Tocagen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Tocagen Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 28. VBL Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. VBL Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 30. Cold Genesys Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Cold Genesys Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 32. Genprex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Genprex Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 34. Momotaro-Gene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Momotaro-Gene Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 36. MultiVir Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. MultiVir Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 38. SynerGene Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. SynerGene Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 40. Ziopharm Oncology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Ziopharm Oncology Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 42. Anchiano Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Anchiano Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 44. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Celgene Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 46. Celsion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Celsion Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 48. Bluebird Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Bluebird Bio Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
